Global synthetic drugs assessment
Hide / Show Abstract

Global synthetic drugs assessment

Amphetamine-type stimulants and new psychoactive substances

The 2014 Global Synthetic Drugs Assessment provides a global and regional analysis of the synthetic drugs market which includes both Amphetamine-Type Stimulants (ATS) and New Psychoactive Substances (NPS). An increase in methamphetamine trafficking has been observed in many regions and a growing range of NPS has become more widely available globally. This report aims to provide an improved understanding of the problem based on scientific evidence and information provided by Member States.
Click to Access: 
    http://oecd.metastore.ingenta.com/content/19d5a8d1-en.pdf
  • PDF
  • http://www.keepeek.com/Digital-Asset-Management/oecd/drugs-crime-and-terrorism/global-synthetic-drugs-assessment_19d5a8d1-en
  • READ
 
Chapter
 

Europe Regional Overview You do not have access to this content

English
Click to Access: 
    http://oecd.metastore.ingenta.com/content/a64e0de1-en.pdf
  • PDF
  • http://www.keepeek.com/Digital-Asset-Management/oecd/drugs-crime-and-terrorism/global-synthetic-drugs-assessment_a64e0de1-en
  • READ
Author(s):
UNODC

Hide / Show Abstract

Amphetamine continues to be the most commonly available synthetic stimulant in Europe, followed by “ecstasy” and methamphetamine. Since 2008, amphetamine seizures have annually made up more than 65 per cent of ATS seizures, whilst “ecstasy” seizures have had an annual share of less than 22 per cent and methamphetamine seizures have annually remained below 13 per cent. Particularly, large amounts of amphetamine were seized in 2008 and in 2009, when amphetamine seizures made up about 80-85 per cent of ATS seizures in Europe.